Since ZNF385A and ZNF346 were rarely mutated in HCC (only one mutation in 353 samples), we analyzed oncogenic driver mutations in ZNF385A and ZNF346 high and low expression groups. This evidence concerns the gene ZNF385A and hepatocellular carcinoma.